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1  | INTRODUC TION
Osteoarthritis	 (OA)	 is	 the	most	 common	 form	 of	 arthritis	 with	
increasing	 prevalence.	 Although	 it	 is	 a	 multifactorial	 disease,	
it	 is	 accepted	 that	 ageing	 can	 induce	 the	 onset	 of	OA	 and	 has	
been	 proposed	 as	 the	 main	 risk	 factor	 of	 this	 pathology.1	 The	
main	 reactive	 oxygen	 species	 (ROS)	 detected	 in	 chondrocytes	
are	 peroxynitrite	 (ONOO−)	 and	 hydrogen	 peroxide	 (H2O2),	 and	
when	 their	 overproduction	 is	 not	 counter‐balanced	 by	 an	 effi‐
cient	 antioxidant	 system,	 the	 oxidative	 stress	 condition	 occurs	
that	 enhances	 cartilage	 degeneration	 and	 OA.2	 Furthermore,	
H2O2	supplementation	has	been	shown	to	elicit	oxidative	stress	
in	 chondrocytes.3,4	 So	 far,	 innovative	 strategies	 of	 treatments	
with	no	side	effects	need	to	be	elucidated.	For	this	purpose,	diet‐
derived	natural	compounds	raised	a	noteworthy	 interest	due	to	
their	preventive	and	therapeutic	action	in	OA.5,6	Hydroxytyrosol	
(HT),	 a	 polyphenol	 contained	 in	 olive	 oil	 and	 derivatives,	 has	
been	 proposed	 as	 a	 fascinating	molecule	 able	 to	 reduce	 oxida‐
tive	 stress‐induced	 cellular	 damage	 and	 to	 change	 epigenetic	
signature	 by	 modulating	 a	 microRNA	 (miR)	 in	 chondrocytes.7,8 
According	 to	 our	 findings,	 miR‐9	 results	 to	 be	 overexpressed	
under	 chondrocyte	 exposure	 to	 H2O2	 and	miR‐9	 dysregulation	
under	 TGF‐β1‐dependent	 ROS	 increase	 has	 been	 reported	 in	
other	 cell	models,9,10	 thus	 confirming	 its	 susceptibility	 to	 redox	
state	and	oxidative	stress.	However,	 the	priming	mechanism	by	
which	oxidative	stress	and	HT	could	trigger	these	modulations	is	
still	 lacking.	 Indeed,	 the	molecular	 key	underlying	 regulation	of	
miR	expression	 in	OA	is	not	completely	clear	and	needs	further	
investigation.	 In	 humans,	miR‐9	 is	 transcribed	 from	 three	 inde‐
pendent	genomic	 loci	mapping	 to	chromosomes	1q22	 (MIR9‐1),	
5q14.3	(MIR9‐2)	and	15q26.1	(MIR9‐3).	Our	present	work	sought	
to	clarify	this	aspect	by	studying	DNA	methylation	of	the	three	
miR‐9	promoters	in	response	to	H2O2	and	HT	treatments	in	C‐28/
I2	chondrocytes.
2  | MATERIAL S AND METHODS
2.1 | Cell cultures and treatments
C‐28/I2	 is	 a	 human	 cell	 line	 representative	 of	 primary	 chondro‐
cytes11	that	has	been	used	for	deeper	molecular	studies	to	provide	
mechanistic	 explanations	 to	 the	 findings	 of	 previous	work	 carried	
out	on	human	primary	chondrocytes.7	Cells,	grown	 in	DMEM	me‐
dium	 supplemented	 with	 10%	 foetal	 bovine	 serum,	 were	 incu‐
bated	in	the	absence	or	presence	of	100	µmol/L	H2O2	for	2	hours;	
100	µmol/L	HT	 (Cayman	Chemical)	was	added	30	minutes	before	
H2O2.	The	concentration	of	HT	was	chosen	on	the	basis	of	a	pub‐
lished	study,12	and	previous	experiments	reported	in	our	published	
manuscripts3,7,13	have	confirmed	the	efficacy	of	this	concentration	
in	protecting	chondrocytes	from	cell	death	with	lack	of	toxicity.	To	
assess	the	effects	of	modulation	of	methylase	activity	on	miR‐9	tran‐
scription,	in	a	separate	series	of	experiments	increasing	doses	of	5′‐
azacytidine	(5′Aza;	1‐50	mmol/L)	(Sigma‐Aldrich)	were	added	to	cells	
24	hours	before	collection.
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2.2 | Cell transfection
C‐28/I2	 cells	 were	 seeded	 in	 6‐well	 plates	 at	 a	 density	 of	
2.5 × 105	 cells/well	 in	 medium	 without	 antibiotics.	 The	 next	 day	
cells	 were	 transfected	 with	 ON‐TARGETplus	 Human	 Sirt1	 siRNA	
(25	 nmol/L)	 or	 ON‐TARGETplus	 non‐targeting	 pool	 (25	 nmol/L)	
(Dharmacon)	by	Lipofectamine®	RNAiMax	Reagent	in	Opti‐MEM®	
Medium	 (Life	 Technologies)	 according	 to	 manufacturer's	 instruc‐
tions	and	incubated	for	48	hours	before	collection.
2.3 | Nucleic acid isolation, bisulfite conversion and 
methylation‐specific PCR
Total	cellular	RNA	and	genomic	DNA	were	extracted	with	700	µL	
TRIZOL	 (Invitrogen),	 according	 to	 manufacturer's	 instructions.	
Human	Methylated	 &	Non‐methylated	DNA	 Set	 (Zymo	 Research,	
Irvine,	CA,	USA)	was	used	to	provide	negative	and	positive	controls.	
500	ng	of	sample	and	control	DNA	was	treated	with	sodium	bisulfite	
using	 the	 EZ	 DNA	 Methylation	 Kit	 (Zymo	 Research,	 Irvine,	 CA,	
USA)	 according	 to	 the	manufacturer's	protocol.	 Six	pairs	of	meth‐
ylation‐specific	 primers	 were	 designed	 by	 the	 online	MethPrimer	
software14	 and	 purchased	 by	 Invitrogen	 (miR‐9‐1	 meth	 forward	
AGGTAGAGGTTTTTTTAGTTTCGTC	and	reverse	AACCTTTCCTCT 
CTCTTTAAATCG;	miR‐9‐1	unmeth	forward	GGTAGAGGTTTTTTTA 
GTTTTGTTG	 and	 reverse	 AACCTTTCCTCTCTCTTTAAATCAC;	
miR‐9‐2	 meth	 forward	 TTGTTAGAAGAAAAATGTAGGTAAAGAC	
and	reverse	CCTACTACCCGAACAACGAC;	miR‐9‐2	unmeth	forward	
TTAGAAGAAAAATGTAGGTAAAGATGT	 and	 reverse	CCTACTACC 
CAAACAACAAC;	miR‐9‐3	meth	forward	TTTGTTTATTTTTTTTGG 
TTTTTCG	 and	 reverse	 CTCTCGACTCCTCTAACTCTTACGA;	 miR‐ 
9‐3	 unmeth	 forward	 GTGTTTGTTTATTTTTTTTGGTTTTTT	 and	
reverse	 TCCTCTCAACTCCTCTAACTCTTACA).	 Primers	 were	 an‐
nealed	at	53°C.	Platinum™	Taq	DNA	Polymerase	(Thermofisher)	was	
used	according	to	the	manufacturer's	protocol.
2.4 | cDNA synthesis and Real‐Time PCR
RNA	 pellets	 were	 treated	 with	 DNAse	 (DNA‐free,	 Ambion)	
and	 quantified	 by	 using	 RiboGreen	 RNA	 quantitation	 reagent	
(Molecular	 Probes).	 MicroRNA	 reverse	 transcription	 was	 con‐
ducted	 with	 TaqMan	 MicroRNA	 RT	 kit	 (Life	 Technologies),	 and	
qPCR	 was	 performed	 with	 TaqMan	 Universal	 Mastermix	 (Life	
Technologies)	 following	 kit	 instructions.	Mature	 miR	 quantifica‐
tion	was	performed	by	using	TaqMan	MicroRNA	Assays	for	miR‐9	
and	U6	snRNA	(internal	control),	according	to	manufacturer's	rec‐
ommended	protocols.
2.5 | Western blotting assay
Proteins	 were	 separated	 on	 10%	 SDS	 polyacrylamide	 gels,	 trans‐
ferred	 to	 nitrocellulose	 membranes	 (Amersham),	 and	 probed	
with	 anti‐β‐ACTIN	 (Sigma‐Aldrich)	 and	 anti‐SIRT1	 (Santa	 Cruz	
Biotechnology)	primary	antibodies	at	4°C	overnight.
After	washes,	membranes	were	incubated	with	horseradish	per‐
oxidase‐conjugated	anti‐mouse	(Santa	Cruz	Biotechnology)	IgG	for	
1	hour.	The	chemiluminescent	signals	were	detected	using	an	ECL	
system	(Luminata™	Crescendo,	Millipore).
2.6 | Statistical analysis
Data	are	reported	as	mean	±	standard	deviation	(SD).	Means	were	
compared	 with	 GraphPad	 Prism5	 statistical	 software	 (GraphPad	
Software,	Inc).	Differences	were	considered	statistically	significant	
at	P < .05.
3  | RESULTS
3.1 | MiR‐9 expression is increased by H2O2‐
induced promoter demethylation
Our	previous	study7	showed	that	miR‐9	levels	 increase	after	treat‐
ment	 with	 H2O2	 and	 decrease	 with	 HT.	 In	 order	 to	 evaluate	 if	
miR‐9	expression	 could	be	 influenced	by	methylation	 status	of	 its	
promoters	 in	our	 cellular	model	 (as	 drawn	 in	Figure	1A),	 5′‐Aza,	 a	
DNA	methyltransferase	 (DNMT)	 inhibitor,	was	used.	The	 levels	of	
miR‐9	 increased	after	5′‐Aza	 treatment	 in	a	dose‐dependent	man‐
ner	 (Figure	 1B).	 Therefore,	 the	 status	 of	 CpG	 islands	 surrounding	
promoters	 of	miR‐9	 genes	 is	 important	 for	 the	 regulation	of	 gene	
expression.
Promoter	methylation	 levels	 of	miR‐9‐1,	miR‐9‐2	 and	miR‐9‐3	
were	assessed	 in	 response	 to	HT	and/or	H2O2	by	using	methyla‐
tion‐specific	 PCR	 (MSP).	 As	 shown	 in	 Figure	 1C,	 levels	 of	miR‐9	
methylation	were	decreased	in	all	three	promoters	of	cells	treated	
with	H2O2	and,	on	the	contrary,	reestablished	after	pretreatment	
with	 HT.	 From	 a	 qualitative	 point	 of	 view,	 no	 difference	 in	 the	
methylation	status	among	the	three	different	promoters	has	been	
observed.
3.2 | SIRT1 silencing determines demethylation of 
miR‐9 promoters
SIRT1	has	been	reported	as	a	genuine	target	of	miR‐9	and	SIRT1	
levels	 decreased	 in	 response	 to	H2O2‐induced	oxidative	 stress.
7 
To	 determine	 whether	 SIRT1	 could	 modulate	 methylation	 of	
miR‐9	promoters	in	a	negative	feedback	loop,	C‐28/I2	cells	were	
depleted	 of	 SIRT1	 by	 RNA	 interference.	 Protein	 samples	 were	
immunoblotted	 with	 SIRT1	 antibody	 to	 test	 the	 transfection	
outcome	(Figure	2A).	Then,	sample	DNA	was	extracted	and	ana‐
lysed	by	MSP.	As	shown	in	Figure	2B,	SIRT1	knockdown	changes	
methylation	status	of	promoters	by	hypomethylating	all	three	of	
them.	However,	we	did	not	observe	a	corresponding	 increase	 in	
miR‐9	expression	 in	SIRT1‐silenced	cells	 (Figure	2C).	Thus,	SIRT1 
knockdown	 by	 siRNA	 transfection	 or	H2O2	 treatment	 can	 dem‐
ethylate	 the	 promoters,	 though	 only	 H2O2	 treatment	 is	 able	 to	
modulate	miR‐9	expression	 in	 response	to	methylation	status	of	
CpG	islands.
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F I G U R E  1  MiR‐9	promoters	are	influenced	by	5′‐Azacytidine,	Hydroxytyrosol	and	Hydrogen	peroxide	treatments.	A,	Schematic	drawing	
of	the	hypothesis	that	miR‐9	expression	is	dependent	on	methylation	status	of	its	promoters.	B,	qRT‐PCR	analysis	of	miR‐9	levels	in	5′‐Aza‐
treated	cells	(n	=	4	independent	experiments).	C,	MSP	analysis	for	methylated	and	unmethylated	sequences	of	miR9‐1,	miR9‐2	and	miR9‐3.	
1	(non‐treated	cells),	2	(HT‐treated	cells),	3	(H2O2‐treated	cells),	4	(HT	+	H2O2‐treated	cells),	M	(universal	methylated	DNA),	U	(universal	
unmethylated	DNA).	Values	are	expressed	as	mean	±	SD,	*P	<	.05,	**P < .01
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4  | DISCUSSION
In	our	previous	work,	we	demonstrated	that	HT,	a	polyphenol	found	
in	olives	 and	derivatives,	 can	prevent	oxidative	 stress‐induced	 cell	
death	and	autophagy	dysfunction	by	modulating	miR‐9	availability	
and	 its	 cognate	 target	SIRT1.	 Thus,	miR‐9	has	been	 identified	 as	 a	
crucial	 factor	 orchestrating	 the	 molecular	 response	 to	 H2O2 and 
HT	in	chondrocytes.7,13	Dysregulated	levels	of	miR‐9	in	OA	patients	
have	been	published,15	and	besides	SIRT‐1,	other	targets	associated	
with	OA	pathogenesis	have	been	reported,	including	MMP‐1316 and 
monocyte	chemo‐attractant	protein	1‐induced	protein	1	(MCPIP‐1).17
Nevertheless,	the	fuse	triggering	the	variations	of	miR	expres‐
sion	was	unknown.	A	genome‐wide	DNA	methylation	study	per‐
formed	 in	OA	cartilage	 identified	miR‐9	 as	 an	OA	 susceptibility	
gene	among	other	factors.18	To	explore	whether	our	treatments	
could	influence	miR‐9	expression	by	modifying	methylation	status	
of	CpG	islands	surrounding	the	three	promoters	of	miR‐9	genes,	
we	treated	the	cells	with	the	DNMT	inhibitor	5′‐Aza	and	detected	
a	dose‐dependent	increase	in	miR‐9	levels.	Furthermore,	all	three	
miR‐9	 promoters	 were	 shown	 to	 be	 hypomethylated	 in	 cells	
treated	with	H2O2	and	hypermethylated	in	cells	treated	with	HT	
alone	 or	 both.	 Taken	 together,	 these	 results	 suggest	 that	 these	
treatments	modulate	miR‐9	expression	by	exerting	opposite	 ef‐
fects	on	 the	promoter	methylation	 status,	with	oxidative	 stress	
reducing	and	HT	rescuing	and	sustaining	the	hypermethylation	of	
CpG	 islands.	 Since	no	methylation	differences	 among	 the	 three	
promoters	have	been	highlighted,	we	could	speculate	that	all	the	
three	genes	contribute	to	the	expression	levels	of	miR‐9.
Since	miR‐9	reduces	 its	direct	 target	SIRT1,	as	demonstrated	by	
luciferase	 assay,7	we	 investigated	whether,	 in	 turn,	 SIRT1	 could	 be	
implicated	 in	the	modulation	of	miR‐9	 levels	 in	a	negative	feedback	
loop.	However,	miR‐9	promoter	 hypomethylation	 induced	by	SIRT1 
F I G U R E  2  MiR‐9	promoters	are	demethylated	by	SIRT1	silencing	without	influencing	gene	expression.	A,	Western	blotting	analysis	of	
SIRT1	and	β‐ACTIN.	Representative	images	and	relative	quantifications	are	shown	(n	=	4	independent	experiments).	B,	MSP	analysis	for	
methylated	and	unmethylated	sequences	of	miR9‐1,	miR9‐2	and	miR9‐3.	C,	qRT‐PCR	analysis	of	miR‐9	levels	in	SIRT1‐silenced	cells	(n	=	4	
independent	experiments).	Values	are	expressed	as	mean	±	SD,	***P < .001
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silencing	through	RNA	interference	did	not	correspond	to	an	increase	
in	miR‐9	expression.	Thus,	demethylation	of	miR‐9	promoters	can	fa‐
vour	but	per	se	may	not	be	sufficient	to	promote	miR‐9	expression.	
It	may	be	hypothesized	that	miR‐9	expression	requires	 the	 involve‐
ment	of	 some	 transcription	 factors,	 triggered	upon	oxidative	stress	
or	 5’‐aza‐induced	 general	 hypomethylation,	 but	 not	 following	 just	
SIRT1	 silencing	 that	may	 elicit	 hypomethylation	 restricted	 to	miR‐9	
promoters.	 If	 previous	work7	 elucidated	 the	 role	 of	 this	miR	 in	 the	
H2O2‐promoted	cell	death	and	in	the	protective	effect	of	HT	in	chon‐
drocytes,	these	new	findings	provide	the	upstream	mechanism	influ‐
encing	the	variations	of	miR‐9	expression.	The	identification	of	a	miR	
able	to	address	the	cell	fate	in	response	to	a	protective	and/or	stress	
agent	opens	novel	perspectives	in	the	field	of	molecular	therapy	for	
degenerative	diseases,	 such	 as	OA.	 Indeed,	 a	 better	 understanding	
of	the	interaction	of	different	epigenetic	 levels	 in	OA	pathogenesis,	
including	promoter	methylation	status,	miR	expression	and	transcrip‐
tome	changes,	could	be	useful	 to	prime	further	 investigations	 for	a	
miR‐based	strategy	with	nutraceutical	support	in	the	treatment	of	this	
disease.
ACKNOWLEDG EMENTS
This	work	was	supported	by	grants	from	University	of	Bologna	(RFO)	
and	Ministero	della	Salute,	Italy	(Fondi	Cinque	per	Mille,	year	2016).
CONFLIC T OF INTERE S T
The	authors	have	declared	that	there	is	no	conflict	of	interest.
AUTHOR CONTRIBUTION
SD	 designed	 the	 experiments.	 SD	 and	 SC	 performed	 the	 experi‐
ments.	SD,	SC,	RMB	and	FF	analysed	and	interpreted	the	data.	SD,	
SC,	RMB	and	FF	contributed	in	writing	and	approving	the	manuscript.
DATA AVAIL ABILIT Y S TATEMENT
The	 datasets	 used	 and/or	 analysed	 during	 the	 current	 study	 are	
available	from	the	corresponding	author	on	reasonable	request.
ORCID
Silvia Cetrullo  https://orcid.org/0000‐0002‐6900‐4910 
R E FE R E N C E S
	 1.	 Blagojevic	M,	Jinks	C,	Jeffery	A,	Jordan	KP.	Risk	factors	for	onset	of	
osteoarthritis	of	the	knee	in	older	adults:	a	systematic	review	and	
meta‐analysis.	Osteoarthr Cartilage.	2010;18(1):24‐33.
	 2.	 Henrotin	 Y,	 Kurz	 B,	 Aigner	 T.	 Oxygen	 and	 reactive	 oxygen	 spe‐
cies	in	cartilage	degradation:	friends	or	foes?	Osteoarthr Cartilage. 
2005;13(8):643‐654.
	 3.	 Facchini	A,	Cetrullo	S,	D'Adamo	S,	et	al.	Hydroxytyrosol	prevents	
increase	of	osteoarthritis	markers	in	human	chondrocytes	treated	
with	 hydrogen	 peroxide	 or	 growth‐related	 oncogene	 alpha.	PLoS 
ONE.	2014;9(10):e109724.
	 4.	 Cheleschi	S,	De	Palma	A,	Pascarelli	NA,	et	al.	Could	oxidative	stress	
regulate	 the	 expression	 of	 MicroRNA‐146a	 and	 MicroRNA‐34a	
in	 human	 osteoarthritic	 chondrocyte	 cultures?	 Int J Mol Sci. 
2017;18(12):E2660.
	 5.	 Ragle	RL,	Sawitzke	AD.	Nutraceuticals	in	the	management	of	osteo‐
arthritis:	a	critical	review.	Drugs Aging.	2012;29(9):717‐731.
	 6.	 Borzi	RM,	Guidotti	S,	Minguzzi	M,	et	al.	Polyamine	delivery	as	a	tool	
to	modulate	stem	cell	differentiation	in	skeletal	tissue	engineering.	
Amino Acids.	2014;46(3):717‐728.
	 7.	 D'Adamo	 S,	 Cetrullo	 S,	 Guidotti	 S,	 Borzi	 RM,	 Flamigni	 F.	
Hydroxytyrosol	modulates	the	levels	of	microRNA‐9	and	its	target	
sirtuin‐1	thereby	counteracting	oxidative	stress‐induced	chondro‐
cyte	death.	Osteoarthritis Cartilage.	2017;25(4):600‐610.
	 8.	 D'Adamo	S,	Cetrullo	S,	Minguzzi	M,	Silvestri	Y,	Borzi	RM,	Flamigni	F.	
MicroRNAs	and	autophagy:	fine	players	in	the	control	of	chondro‐
cyte	homeostatic	activities	in	osteoarthritis.	Oxid Med Cell Longev. 
2017;2017:3720128.
	 9.	 Fierro‐Fernandez	 M,	 Busnadiego	 O,	 Sandoval	 P,	 et	 al.	 miR‐9‐5p	
suppresses	 pro‐fibrogenic	 transformation	 of	 fibroblasts	 and	 pre‐
vents	organ	 fibrosis	by	 targeting	NOX4	and	TGFBR2.	EMBO Rep. 
2015;16(10):1358‐1377.
	10.	 Meseguer	 S,	 Martinez‐Zamora	 A,	 Garcia‐Arumi	 E,	 Andreu	 AL,	
Armengod	ME.	The	ROS‐sensitive	microRNA‐9/9*	controls	the	ex‐
pression	of	mitochondrial	tRNA‐modifying	enzymes	and	is	involved	
in	the	molecular	mechanism	of	MELAS	syndrome.	Hum Mol Genet. 
2015;24(1):167‐184.
	11.	 Finger	 F,	 Schorle	 C,	 Zien	 A,	 Gebhard	 P,	 Goldring	 MB,	 Aigner	 T.	
Molecular	phenotyping	of	human	chondrocyte	cell	lines	T/C‐28a2,	
T/C‐28a4,	and	C‐28/I2.	Arthritis Rheum.	2003;48(12):3395‐3403.
	12.	 Warleta	F,	Quesada	CS,	Campos	M,	Allouche	Y,	Beltran	G,	Gaforio	
JJ.	 Hydroxytyrosol	 protects	 against	 oxidative	 DNA	 damage	 in	
human	breast	cells.	Nutrients.	2011;3(10):839‐857.
	13.	 Cetrullo	 S,	 D'Adamo	 S,	 Guidotti	 S,	 Borzi	 RM,	 Flamigni	 F.	
Hydroxytyrosol	 prevents	 chondrocyte	 death	 under	 oxida‐
tive	 stress	 by	 inducing	 autophagy	 through	 sirtuin	 1‐depen‐
dent	 and	 ‐independent	 mechanisms.	 Biochim Biophys Acta. 
2016;1860(6):1181‐1191.
	14.	 Li	 LC,	 Dahiya	 R.	 MethPrimer:	 designing	 primers	 for	 methylation	
PCRs.	Bioinformatics.	2002;18(11):1427‐1431.
	15.	 Iliopoulos	D,	Malizos	KN,	Oikonomou	P,	Tsezou	A.	Integrative	mi‐
croRNA	 and	 proteomic	 approaches	 identify	 novel	 osteoarthritis	
genes	 and	 their	 collaborative	 metabolic	 and	 inflammatory	 net‐
works.	PLoS ONE.	2008;3(11):e3740.
	16.	 Jones	SW,	Watkins	G,	Le	Good	N,	et	al.	The	identification	of	differ‐
entially	expressed	microRNA	in	osteoarthritic	tissue	that	modulate	
the	production	of	TNF‐alpha	and	MMP13.	Osteoarthritis Cartilage. 
2009;17(4):464‐472.
	17.	 Makki	MS,	Haseeb	A,	Haqqi	TM.	MicroRNA‐9	promotion	of	inter‐
leukin‐6	expression	by	 inhibiting	monocyte	chemoattractant	pro‐
tein‐induced	 protein	 1	 expression	 in	 interleukin‐1beta‐stimulated	
human	chondrocytes.	Arthritis Rheumatol.	2015;67(8):2117‐2128.
	18.	 Jeffries	MA,	Donica	M,	Baker	LW,	et	al.	Genome‐wide	DNA	meth‐
ylation	study	identifies	significant	epigenomic	changes	in	osteoar‐
thritic	cartilage.	Arthritis Rheumatol.	2014;66(10):2804‐2815.
How to cite this article:	D’Adamo	S,	Cetrullo	S,	Borzì	RM,	
Flamigni	F.	Effect	of	oxidative	stress	and	3‐hydroxytyrosol	on	
DNA	methylation	levels	of	miR‐9	promoters.	J Cell Mol Med. 
2019;23:7885–7889. https	://doi.org/10.1111/jcmm.14657	
